bioRxivBioinformaticsPreprint
Extending the small molecule similarity principle to all levels of biology
Miquel Duran‐FrigolaiD, Eduardo PaulsiD, Oriol Guitart-PlaiD, Martino BertoniiD, Modesto Orozco-RuiziD, Víctor AlcaldeiD, Víctor M. DiaziD, Antonio BerengueriD, David Amat, Teresa Juan-BlancoiD, Antonio Garcı́a de HerrerosiD, Patrick AloyiD
Abstract
We present the Chemical Checker (CC), a resource that provides processed, harmonized and integrated bioactivity data on 800,000 small molecules. The CC divides data into five levels of increasing complexity, ranging from the chemical properties of compounds to their clinical outcomes. In between, it considers targets, off-targets, perturbed biological networks and several cell-based assays such as gene expression, growth inhibition and morphological profilings. In the CC, bioactivity data are expressed in a vector format, which naturally extends the notion of chemical similarity between compounds to similarities between bioactivity signatures of different kinds. We show how CC signatures can boost the performance of drug discovery tasks that typically capitalize on chemical descriptors, including target identification and library characterization. Moreover, we demonstrate and experimentally validate that CC signatures can be used to reverse and mimic biological signatures of disease models and genetic perturbations, options that are otherwise impossible using chemical information alone.
- Citations
- 5
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integration of diverse bioactivity data into the Chemical Checker compound universe
Arnau Comajuncosa-Creus, Martino Bertoni, … Patrick Aloy·Nature ProtocolsPeer-reviewed·May 21, 2025
- Bioactivity descriptors for uncharacterized compounds
Martino Bertoni, Miquel Duran‐Frigola, … Patrick Aloy·bioRxiv·Jul 21, 2020
- Bioactivity assessment of natural compounds using machine learning models based on drug target similarity
Vinita Periwal, Stefan Oliver Bassler, … Athanasios Typas·bioRxiv·Nov 6, 2020
- Improving prediction of compound function from chemical structure using chemical-genetic networks
Hamid Safizadeh, Scott W. Simpkins, … Chad L. Myers·Journal of Chemical Information and ModelingPeer-reviewed·Jul 28, 2021
- Stereochemically-aware bioactivity descriptors for uncharacterized chemical compounds
Arnau Comajuncosa-Creus, Aksel Lenes, … Patrick Aloy·Journal of CheminformaticsPeer-reviewed·Jun 18, 2024
- Do molecular fingerprints identify diverse active drugs in large-scale virtual screening? (no)
V. Venkatraman, A. Roy, … T. Wheeler·bioRxiv·Sep 20, 2022